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Synthesis of Pyridone Ligands and Iron Precursors for the Development of
Iron-based Hydrogenation Catalysts
Becky Hanscam*, Prof. Luc Boisvert
Department of Chemistry, University of Puget Sound, Summer 2015
Synthesis of Ligands

Background
• Hydrogenation is a key reaction in many multistep chemical syntheses.

Oxazoline Ligand:

- Requires the addition of a metal catalyst.

- Largely adopted by the pharmaceutical industry
as a cost-effective and green approach to a wide
range of compounds.
• Known efficient catalysts are based on the
expensive and toxic transition metals Ir, Ru, Rh.
• Proposed iron-based hydrogenation catalysts:
inexpensive and nontoxic

• Step 1b: seven deprotection attempts were made, but more work is necessary.
- Acidic conditions (HBr, HCl, AcOH, BBr3) were too harsh, forming black sludge along with low yields of the product.
- Nucleophilic conditions (LiCl, TMSCl and NaI) were too mild, presence of the starting material confirmed by 1H NMR.

Conclusions
• Ligands 1 and 3 were both synthesized.
• In the formation of ligand 2, acidic conditions were
too harsh and the nucleophilic conditions tested were
too mild.
• Ligand 4 was synthesized, but a side-product formed
in the conditions tested.
• Six iron precursors synthesized through Pathway A.
• Pathway C attempts to form iron precursors were
unsuccessful.

Future Work
Iron Precursors:

Imidazole Ligand:

- Several iron-based hydrogenation catalysts are
known but there is ample room for
improvement.1
- A key step for hydrogenation is the formation of
a Fe-H bond through ligand-assisted heterolytic
cleavage of H2.
- We propose to use a pyridone ligand attached to
the metal center to act as base in the activation
of H2:

• Step 1: following the procedure optimized by Hayley Caddes (2014); formation of the product confirmed by 1H NMR analysis.
• Step 2: successful deprotection under acidic conditions and heat.
- Formation of the product confirmed by 1H NMR spectroscopy, including the absence of a methyl peak at 4.0 ppm.
• Step 3: successful attachment of ethyl group in DMF.
- Presence of a quartet at 4.6 ppm and a triplet at 1.6 ppm in the 1H NMR spectrum are consistent with values reported in the literature, as well as the hydrogen
on the imidazole ring shifting up to 10.5 ppm.5
- Excess EtI reacts at other locations forming an unknown side-product seen by 1H NMR spectroscopy.
- Using DMF at room temperature yielded the best outcome with a 1:1 product/side-product ratio.
- No reaction occurred with any other solvent (THF, CH3CN, EtOAc, toluene, acetone); the starting material was insoluble in most of them.

Formation of Iron Complexes
Pathway A:
- This mechanism, which has proven to be
effective for known non-iron catalysts, is not
documented for iron.2

• The reported formation of iron complexes 22a and
22b will be investigated as they could serve as highly
reactive iron precursors.7,8
• More trials of pathways A, B, and C will be
conducted.
• More attempts of the attachment of bipyridine will be
conducted and analyzed with IR spectroscopy.5
• Further analysis will be done on pathway B.

Synthesis of Ligands:
• Further attempts of Step 2b of oxazoline ligand
synthesis will be done under nucleophilic conditions.
• More trials of Step 4 in the synthesis of the imidazole
ligand will be conducted, as well as further
investigation of the solubility of the product.

Objectives of the Research
• Synthesize pyridone-based ligands
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• Synthesize iron complex precursors

Pathway B:
• Test iron precursors by attempting to
attach model ligand 2,2’-bipyridine (bipy).

• Step 1: yellow-white powdery solid synthesized following procedure developed by Liz Meucci (2014).
- 11a and 11b are paramagnetic so 1H NMR spectra are unhelpful.
• Step 2a: black solid formed that is consistent with descriptions in the literature but insoluble in all
solvents tried; unable to analyze by 1H NMR spectroscopy .6
• Step 2b: unsuccessful attachment of Cp ring confirmed by 1H NMR signals inconsistent with those in
the literature.6

Pathway C:
• Step 1: previously performed successfully by Liz Meucci (2014).
• Step 2a: unsuccessful attachment of Cp* ring confirmed by the absence of
a signal for the methyl groups on the Cp*ring in 1H NMR.
• Step 2b: unsuccessful attachment of Cp ring confirmed by an 1H NMR
spectrum that was identical to that of step 2a.
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